Sarepta Therapeutics, Inc.
$2.27B- Market cap
- $2.38B
- Debt
- +$828.97M
- Cash
- −$939.65M
Capital structure 74% equity / 26% debt · EV / Revenue 1.03x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SRPT · current priceP/S 1.08x
$22.52Latest market snapshot
Implied fair value · at PLTK's multiple
$6.4071.6% below market
20.81 SRPT revenue / share×0.31x PLTK P/S=$6.40
Market $22.52Implied $6.40
PLTK · current priceP/S 0.31x
$2.22Latest market snapshot
Implied fair value · at SRPT's multiple
$7.82252.1% above market
7.22 PLTK revenue / share×1.08x SRPT P/S=$7.82
Market $2.22Implied $7.82